In the latest episode of TrailblAZers, AstraZeneca's Penny George speaks with Medicines Australia chief executive Liz de Somer about the 2024-25 Budget and the industry's hope for a positive outcome from the Health Technology Assessment Review.
In the latest episode of TrailblAZers, AstraZeneca's Penny George speaks with Medicines Australia chief executive Liz de Somer about the 2024-25 Budget and the industry's hope for a positive outcome from the Health Technology Assessment Review.